These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization. Najafabadi FF; Hendimarjan SM; Zarrin Y; Najafabadi MF J Ophthalmic Vis Res; 2015; 10(4):484-6. PubMed ID: 27051495 [TBL] [Abstract][Full Text] [Related]
6. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin). Ahmadieh H; Vafi N Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1731-3. PubMed ID: 17653753 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma. Yoshikawa T; Takahashi K Clin Ophthalmol; 2015; 9():429-37. PubMed ID: 25784788 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma. Wu ZH; Wong MY; Lai TY Case Rep Ophthalmol; 2012 May; 3(2):200-4. PubMed ID: 22740831 [TBL] [Abstract][Full Text] [Related]
9. [Intravitreal injection of bevacizumab for CNV secondary to choroidal osteoma and follow-up by Spectral-Domain OCT]. Mercé E; Korobelnik JF; Delyfer MN; Rougier MB J Fr Ophtalmol; 2012 Sep; 35(7):508-13. PubMed ID: 22695057 [TBL] [Abstract][Full Text] [Related]
13. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab. Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547 [TBL] [Abstract][Full Text] [Related]
14. Focal Choroidal Excavation in a Case of Choroidal Osteoma Associated with Choroidal Neovascularization. Azimizadeh M; Hosseini SM; Babaei E J Ophthalmic Vis Res; 2020; 15(3):419-423. PubMed ID: 32864073 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma. Narayanan R; Shah VA Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736 [TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography Angiography for Detecting Choroidal Neovascularization Secondary to Choroidal Osteoma. Szelog JT; Bonini Filho MA; Lally DR; de Carlo TE; Duker JS Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):69-72. PubMed ID: 26731212 [TBL] [Abstract][Full Text] [Related]
18. Assessment of choroidal osteoma complicating choroidal neovascularization by optical coherence tomography angiography. Shen C; Yan S; Du M; Zhao H; Shao L; Hu Y Int Ophthalmol; 2018 Apr; 38(2):787-792. PubMed ID: 28364338 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma. Papastefanou VP; Pefkianaki M; Al Harby L; Arora AK; Cohen VM; Andrews RM; Sagoo MS Eye (Lond); 2016 Jun; 30(6):843-9. PubMed ID: 27034203 [TBL] [Abstract][Full Text] [Related]
20. Analysis of outcomes for intravitreal bevacizumab in the treatment of choroidal neovascularization secondary to ocular histoplasmosis. Cionni DA; Lewis SA; Petersen MR; Foster RE; Riemann CD; Sisk RA; Hutchins RK; Miller DM Ophthalmology; 2012 Feb; 119(2):327-32. PubMed ID: 22133795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]